Showing results (381-390 of 573) with videos related to

Sort By:
Pageof 58
Therapeutic Advances in Infectious Disease|January 9, 2025
Distribution and antifungal susceptibility of Candida species causing vulvovaginal candidiasis and urinary tract infection in Medlatec healthcare system, Ha Noi city, Vietnam in 2023Pham Van Ngai, Tran Huu Dat, Luu Yen Nhi, et al.
Therapeutic Advances in Infectious Disease|December 9, 2024
External validation of ID-BactER and Shapiro scores for predicting bacteraemia in the emergency departmentSebastián Quintero Montealegre, Andrés Felipe Flórez Monroy, Javier Ricardo Garzón Herazo, et al.
Therapeutic Advances in Infectious Disease|December 9, 2024
Pre-exposure prophylaxis access, uptake and usage by young people: a systematic review of barriers and facilitatorsSarah Warzywoda, James A Fowler, Amalie Dyda, et al.
Therapeutic Advances in Infectious Disease|November 4, 2024
Impact of an antibiotic stewardship program on adherence to antibiotic prescription in children admitted with urinary tract infectionGiulia Brigadoi, Cecilia Liberati, Emelyne Gres, et al.
Therapeutic Advances in Infectious Disease|November 15, 2024
Polio: Background and perspective on how international travel can be made safe against polioDhanya Dharmapalan, Thekkekara Jacob John, Robert Steinglass, et al.
Therapeutic Advances in Infectious Disease|November 11, 2024
Emerging trends in fungal endocarditis: clinical complexity, diagnostic challenges, and therapeutic implications - a case series and literature reviewSanthanam Naguthevar, Akshatha Ravindra, Deepak Kumar, et al.
Therapeutic Advances in Infectious Disease|July 29, 2024
Barriers and facilitators to pre-exposure prophylaxis uptake among Black/African American men who have sex with other men in Iowa: COM-B model analysisOluwafemi Adeagbo
Therapeutic Advances in Infectious Disease|November 2, 2023
Antileishmanial activity of 5-nitroindazole derivativesNiurka Mollineda-Diogo, Claudia Sissely Chaviano-Montes de Oca, Sergio Sifontes-Rodríguez, et al.
Therapeutic Advances in Infectious Disease|April 1, 2024
Annexin A2 antibodies in post-treatment Lyme diseaseJohn B Miller, Alison W Rebman, Marcia Daniela Villegas de Flores, et al.
Therapeutic Advances in Infectious Disease|September 5, 2023
An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapyAbby C Bradley, Mary Joyce B Wingler, Katherine L Artman, et al.
Pageof 58